BioCentury
ARTICLE | Company News

Oncovir, Quest Pharma deal

February 3, 2014 8:00 AM UTC

Quest and Oncovir partnered to evaluate Quest's oregovomab in combination with Oncovir's Hiltonol ( Poly-ICLC) adjuvant in an Italian Phase II trial in 20 patients with ovarian cancer, which is expec...